HOME >> BIOLOGY >> NEWS
UC Davis M.I.N.D. Institute launches new program to identify biomarkers for autism and other disorders

(SACRAMENTO, Calif.)-- The UC Davis M.I.N.D. Institute is allocating $1 million to develop a new neurodevelopmental genomics laboratory for the study of biomarkers and other early warning signs of autism and neurodevelopmental disorders. (M.I.N.D. stands for the Medical Investigation of Neurodevelopmental Disorders.) Using the power of the human genome project, the lab aims to identify a genetic profile, or 'fingerprint', of those children who may be vulnerable to autism.

The new laboratory is being developed, in part, in response to last year's landmark research on biomarkers, which was funded by the M.I.N.D. Institute and conducted by the California Birth Defects Monitoring Foundation. This research showed that certain proteins in blood samples taken from babies just hours old could predict which children would later develop autism or mental retardation.

"It is the highest priority of the M.I.N.D. Institutes research program to continue this important research on biomarkers," said David G. Amaral, research director of the M.I.N.D. Institute. "Our goal is to develop a diagnostic test within five years to accurately identify those newborns who are likely to develop autism. Identification of susceptible children is the first step to prevention of full-blown autism, and if we can prevent even 10 percent of the new cases of autism, that will be a major accomplishment."

Autism is a debilitating neurodevelopmental disorder that appears to be on the rise in California and throughout the country. In 1999 alone, more than 2,000 children with severe autism were added to the roles of the Department of Developmental Services (DDS). In addition to the devastating effect this disorder has on families with an autistic child, the DDS estimates that the lifetime cost of care for each of these children is over $2 million.

While the cause of autism is unknown, substantial evidence points to a genetic component. Additional research is needed to determine whether
'"/>

Contact: Carole Gan
cfgan@ucdavis.edu
916-734-9047
University of California, Davis - Health System
1-Jan-2001


Page: 1 2

Related biology news :

1. Controversial UK badger killings analyzed by UC Davis expert
2. New angle needed to get pike out of Lake Davis
3. UC Davis to begin identifying eligible families for study on environmental factors in autism
4. NSF establishes center for biophotonics at UC Davis
5. UC Davis mathematician, neuroscientist win Sloan Fellowships
6. Next-generation AIDS vaccine for healthy individuals being tested for safety, tolerability at UC Davis
7. UC Davis first cloned calf born, succumbs three days later
8. UC Davis biomedical engineering department awarded $12 million by Whitaker Foundation
9. UC Davis study finds breastfeeding may protect bones in teen-age mothers
10. UC Davis, Santa Barbara get $6 million to help estuaries
11. UC Davis science, engineering and technology newstips -- March

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/4/2019)... , ... October 04, 2019 , ... ... will be held November 10 at the Grand Elysée Hamburg Rothenbaumchaussee in Hamburg. ... Europe again this November,” said Miao Guo, Vice President of Operations and spokesperson ...
(Date:10/3/2019)... ... October 01, 2019 , ... The ... of chemicals, reagents, and medias and to be a more environmentally sustainable evolution ... culmination of years of experience and feedback from the original version we launched ...
(Date:10/3/2019)... ... 02, 2019 , ... Connecticut Innovations (CI), Connecticut’s strategic venture ... innovative, growing companies, today announced that it has closed on a $750,000 investment ... the 2018 VentureClash competition. , The outlay is part of ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... ... October 02, 2019 , ... Rapid Novor, Inc., ... announce that it has moved into a new, 5000 sqft, purpose-built, state-of-the-art facility. ... facility demonstrates the company's continuous commitment to quality research and service offerings. ...
(Date:9/24/2019)... ... September 24, 2019 , ... ... technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer ... focused on the development of therapies to treat central nervous system (CNS) ...
(Date:9/17/2019)... ... 2019 , ... Catalent, a global leader in clinical supply ... Pacific (APAC) will present at the upcoming 3rd Annual Accelerating Clinical Trials in ... Thursday, Sept. 26, at 10:10 a.m., Ms. Delaney will present “Singapore: APAC’s Clinical ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
Breaking Biology Technology:
Cached News: